Inventor · disambiguated record
Yuji Kasuya
Also filed as: KASUYA YUJI
19 granted patents·5 pending applications·216 citations·filing 2005–2024
94Inventor score
Top patents by PatentIndex Score
24 records- 0197US10729782B2Antibody-drug conjugate produced by binding through linker having hydrophilic structureDAIICHI SANKYO CO LTD·Filed 2017·Granted Aug 4, 2020·18 cites·13 claims
- 0297US9808537B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Nov 7, 2017·44 cites·18 claims
- 0396US10973924B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Apr 13, 2021·9 cites·2 claims
- 0496US10195288B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2013·Granted Feb 5, 2019·43 cites·35 claims
- 0595US10155821B2Anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Dec 18, 2018·17 cites·8 claims
- 0695US9872924B2Antibody-drug conjugate produced by binding through linker having hydrophilic structureDAIICHI SANKYO CO LTD·Filed 2013·Granted Jan 23, 2018·36 cites·47 claims
- 0793US11795236B2Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Oct 24, 2023·6 cites·12 claims
- 0893US11584800B2Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Feb 21, 2023·2 cites·7 claims
- 0993US9803199B2Cationic lipidDAIICHI SANKYO CO LTD·Filed 2014·Granted Oct 31, 2017·31 cites·29 claims
- 1089US2025049782A1Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 1187US12186310B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2023·Granted Jan 7, 2025·0 cites·1 claims
- 1285US11633493B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Apr 25, 2023·1 cites·14 claims
- 1383US2024026030A1Method of treating cancer comprising administration of anti-her2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2023·Application pending·0 cites
- 1480US10202606B2Complex containing oligonucleotide having immunopotentiating activity and use thereofNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2014·Granted Feb 12, 2019·6 cites·28 claims
- 1579US10533176B2Cationic lipidDAIICHI SANKYO CO LTD·Filed 2017·Granted Jan 14, 2020·2 cites·45 claims
- 1677US11015202B2Complex containing oligonucleotide having immunopotentiating activity and use thereofNAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2018·Granted May 25, 2021·1 cites·9 claims
- 1774US10731159B2Cationic lipidDAIICHI SANKYO CO LTD·Filed 2019·Granted Aug 4, 2020·0 cites·19 claims
- 1864US10808006B2Sustained-release pharmaceutical composition for treatment and prevention of eye diseaseDAIICHI SANKYO CO LTD·Filed 2019·Granted Oct 20, 2020·0 cites·12 claims
- 1957US10208082B2Sustained-release pharmaceutical composition for treatment and prevention of eye diseaseDAIICHI SANKYO CO LTD·Filed 2015·Granted Feb 19, 2019·0 cites·12 claims
- 2056US2011269942A1Antibodies modified with hydrophobic moleculeDAIICHI SANKYO CO LTD·Filed 2008·Application pending·0 cites
- 2153US2024000954A1Complex of beta-glucan and nucleic acid having controlled particle sizeDAIICHI SANKYO CO LTD·Filed 2021·Application pending·0 cites
- 2238US11185594B2(Anti-HER2 antibody)-drug conjugateDAIICHI SANKYO CO LTD·Filed 2015·Granted Nov 30, 2021·0 cites·11 claims
- 2338US7811556B2Polymeric modifiers and pharmaceutical compositionsSANKYO CO·Filed 2005·Granted Oct 12, 2010·0 cites·53 claims
- 2433US2018311278A1Pharmaceutical preparation for delivery of porous material to large intestine or lower part of small intestineDAIICHI SANKYO CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yuji Kasuya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →